The global Biomaterials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biomaterials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biomaterials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Biomaterials include Abbott, Actavis, Anika Therapeutics, Arthrex, Berkeley Advanced Biomaterials(BAB), Zimmer Biomet, Johnson & Johnson, Invibio and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomaterials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomaterials.
Report Scope
The Biomaterials market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomaterials market comprehensively. Regional market sizes, concerning products by Materials, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomaterials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Materials, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott
Actavis
Anika Therapeutics
Arthrex
Berkeley Advanced Biomaterials(BAB)
Zimmer Biomet
Johnson & Johnson
Invibio
Medtronic
Organogenesis
Stryker
Wright Medical Group N.V.
3M Healthcare
Advansource Biomaterials Corporation
Baxter
Covestro
Solvay Advanced Polymers
Segment by Materials
Metallic Biomaterial
Ceramic Biomaterial
Polymeric Biomaterial
Natural Biomaterial
Composites
Segment by Application
Medical Application
Laboratories
Industrial Application
Research Institutions
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Materials, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biomaterials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Biomaterials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Biomaterials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Materials, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Biomaterials 麻豆原创 Overview
1.1 Product Definition
1.2 Biomaterials Segment by Materials
1.2.1 Global Biomaterials 麻豆原创 Value Growth Rate Analysis by Materials 2023 VS 2030
1.2.2 Metallic Biomaterial
1.2.3 Ceramic Biomaterial
1.2.4 Polymeric Biomaterial
1.2.5 Natural Biomaterial
1.2.6 Composites
1.3 Biomaterials Segment by Application
1.3.1 Global Biomaterials 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Medical Application
1.3.3 Laboratories
1.3.4 Industrial Application
1.3.5 Research Institutions
1.3.6 Other
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Biomaterials Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Biomaterials Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Biomaterials Production Estimates and Forecasts (2019-2030)
1.4.4 Global Biomaterials 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Biomaterials Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Biomaterials Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Biomaterials, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Biomaterials 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Biomaterials Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Biomaterials, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Biomaterials, Product Offered and Application
2.8 Global Key Manufacturers of Biomaterials, Date of Enter into This Industry
2.9 Biomaterials 麻豆原创 Competitive Situation and Trends
2.9.1 Biomaterials 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Biomaterials Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Biomaterials Production by Region
3.1 Global Biomaterials Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Biomaterials Production Value by Region (2019-2030)
3.2.1 Global Biomaterials Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Biomaterials by Region (2025-2030)
3.3 Global Biomaterials Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Biomaterials Production by Region (2019-2030)
3.4.1 Global Biomaterials Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Biomaterials by Region (2025-2030)
3.5 Global Biomaterials 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Biomaterials Production and Value, Year-over-Year Growth
3.6.1 North America Biomaterials Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Biomaterials Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Biomaterials Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Biomaterials Production Value Estimates and Forecasts (2019-2030)
4 Biomaterials Consumption by Region
4.1 Global Biomaterials Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Biomaterials Consumption by Region (2019-2030)
4.2.1 Global Biomaterials Consumption by Region (2019-2024)
4.2.2 Global Biomaterials Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Biomaterials Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Biomaterials Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Biomaterials Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Biomaterials Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Biomaterials Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Biomaterials Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Biomaterials Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Biomaterials Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Materials
5.1 Global Biomaterials Production by Materials (2019-2030)
5.1.1 Global Biomaterials Production by Materials (2019-2024)
5.1.2 Global Biomaterials Production by Materials (2025-2030)
5.1.3 Global Biomaterials Production 麻豆原创 Share by Materials (2019-2030)
5.2 Global Biomaterials Production Value by Materials (2019-2030)
5.2.1 Global Biomaterials Production Value by Materials (2019-2024)
5.2.2 Global Biomaterials Production Value by Materials (2025-2030)
5.2.3 Global Biomaterials Production Value 麻豆原创 Share by Materials (2019-2030)
5.3 Global Biomaterials Price by Materials (2019-2030)
6 Segment by Application
6.1 Global Biomaterials Production by Application (2019-2030)
6.1.1 Global Biomaterials Production by Application (2019-2024)
6.1.2 Global Biomaterials Production by Application (2025-2030)
6.1.3 Global Biomaterials Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Biomaterials Production Value by Application (2019-2030)
6.2.1 Global Biomaterials Production Value by Application (2019-2024)
6.2.2 Global Biomaterials Production Value by Application (2025-2030)
6.2.3 Global Biomaterials Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Biomaterials Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Abbott
7.1.1 Abbott Biomaterials Corporation Information
7.1.2 Abbott Biomaterials Product Portfolio
7.1.3 Abbott Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Abbott Main Business and 麻豆原创s Served
7.1.5 Abbott Recent Developments/Updates
7.2 Actavis
7.2.1 Actavis Biomaterials Corporation Information
7.2.2 Actavis Biomaterials Product Portfolio
7.2.3 Actavis Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Actavis Main Business and 麻豆原创s Served
7.2.5 Actavis Recent Developments/Updates
7.3 Anika Therapeutics
7.3.1 Anika Therapeutics Biomaterials Corporation Information
7.3.2 Anika Therapeutics Biomaterials Product Portfolio
7.3.3 Anika Therapeutics Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Anika Therapeutics Main Business and 麻豆原创s Served
7.3.5 Anika Therapeutics Recent Developments/Updates
7.4 Arthrex
7.4.1 Arthrex Biomaterials Corporation Information
7.4.2 Arthrex Biomaterials Product Portfolio
7.4.3 Arthrex Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Arthrex Main Business and 麻豆原创s Served
7.4.5 Arthrex Recent Developments/Updates
7.5 Berkeley Advanced Biomaterials(BAB)
7.5.1 Berkeley Advanced Biomaterials(BAB) Biomaterials Corporation Information
7.5.2 Berkeley Advanced Biomaterials(BAB) Biomaterials Product Portfolio
7.5.3 Berkeley Advanced Biomaterials(BAB) Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Berkeley Advanced Biomaterials(BAB) Main Business and 麻豆原创s Served
7.5.5 Berkeley Advanced Biomaterials(BAB) Recent Developments/Updates
7.6 Zimmer Biomet
7.6.1 Zimmer Biomet Biomaterials Corporation Information
7.6.2 Zimmer Biomet Biomaterials Product Portfolio
7.6.3 Zimmer Biomet Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Zimmer Biomet Main Business and 麻豆原创s Served
7.6.5 Zimmer Biomet Recent Developments/Updates
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Biomaterials Corporation Information
7.7.2 Johnson & Johnson Biomaterials Product Portfolio
7.7.3 Johnson & Johnson Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Johnson & Johnson Main Business and 麻豆原创s Served
7.7.5 Johnson & Johnson Recent Developments/Updates
7.8 Invibio
7.8.1 Invibio Biomaterials Corporation Information
7.8.2 Invibio Biomaterials Product Portfolio
7.8.3 Invibio Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Invibio Main Business and 麻豆原创s Served
7.7.5 Invibio Recent Developments/Updates
7.9 Medtronic
7.9.1 Medtronic Biomaterials Corporation Information
7.9.2 Medtronic Biomaterials Product Portfolio
7.9.3 Medtronic Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Medtronic Main Business and 麻豆原创s Served
7.9.5 Medtronic Recent Developments/Updates
7.10 Organogenesis
7.10.1 Organogenesis Biomaterials Corporation Information
7.10.2 Organogenesis Biomaterials Product Portfolio
7.10.3 Organogenesis Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Organogenesis Main Business and 麻豆原创s Served
7.10.5 Organogenesis Recent Developments/Updates
7.11 Stryker
7.11.1 Stryker Biomaterials Corporation Information
7.11.2 Stryker Biomaterials Product Portfolio
7.11.3 Stryker Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Stryker Main Business and 麻豆原创s Served
7.11.5 Stryker Recent Developments/Updates
7.12 Wright Medical Group N.V.
7.12.1 Wright Medical Group N.V. Biomaterials Corporation Information
7.12.2 Wright Medical Group N.V. Biomaterials Product Portfolio
7.12.3 Wright Medical Group N.V. Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Wright Medical Group N.V. Main Business and 麻豆原创s Served
7.12.5 Wright Medical Group N.V. Recent Developments/Updates
7.13 3M Healthcare
7.13.1 3M Healthcare Biomaterials Corporation Information
7.13.2 3M Healthcare Biomaterials Product Portfolio
7.13.3 3M Healthcare Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.13.4 3M Healthcare Main Business and 麻豆原创s Served
7.13.5 3M Healthcare Recent Developments/Updates
7.14 Advansource Biomaterials Corporation
7.14.1 Advansource Biomaterials Corporation Biomaterials Corporation Information
7.14.2 Advansource Biomaterials Corporation Biomaterials Product Portfolio
7.14.3 Advansource Biomaterials Corporation Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Advansource Biomaterials Corporation Main Business and 麻豆原创s Served
7.14.5 Advansource Biomaterials Corporation Recent Developments/Updates
7.15 Baxter
7.15.1 Baxter Biomaterials Corporation Information
7.15.2 Baxter Biomaterials Product Portfolio
7.15.3 Baxter Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Baxter Main Business and 麻豆原创s Served
7.15.5 Baxter Recent Developments/Updates
7.16 Covestro
7.16.1 Covestro Biomaterials Corporation Information
7.16.2 Covestro Biomaterials Product Portfolio
7.16.3 Covestro Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Covestro Main Business and 麻豆原创s Served
7.16.5 Covestro Recent Developments/Updates
7.17 Solvay Advanced Polymers
7.17.1 Solvay Advanced Polymers Biomaterials Corporation Information
7.17.2 Solvay Advanced Polymers Biomaterials Product Portfolio
7.17.3 Solvay Advanced Polymers Biomaterials Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Solvay Advanced Polymers Main Business and 麻豆原创s Served
7.17.5 Solvay Advanced Polymers Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Biomaterials Industry Chain Analysis
8.2 Biomaterials Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Biomaterials Production Mode & Process
8.4 Biomaterials Sales and 麻豆原创ing
8.4.1 Biomaterials Sales Channels
8.4.2 Biomaterials Distributors
8.5 Biomaterials Customers
9 Biomaterials 麻豆原创 Dynamics
9.1 Biomaterials Industry Trends
9.2 Biomaterials 麻豆原创 Drivers
9.3 Biomaterials 麻豆原创 Challenges
9.4 Biomaterials 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Abbott
Actavis
Anika Therapeutics
Arthrex
Berkeley Advanced Biomaterials(BAB)
Zimmer Biomet
Johnson & Johnson
Invibio
Medtronic
Organogenesis
Stryker
Wright Medical Group N.V.
3M Healthcare
Advansource Biomaterials Corporation
Baxter
Covestro
Solvay Advanced Polymers
听
听
*If Applicable.
